Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology

• DOI: 10.6004/jnccn.2017.0116
• Publication Date: 2017-09-18T19:17:07Z
• Authors: Margaret R. O'Don...; Martin S. Tallman; Camille N. Abboud; Jessica K. Altman; Frederick R. Appe...; Daniel A. Arber; Vijaya Bhatt; Dale Bixby; William Blum; Steven E. Coutre; Marcos De Lima; Amir T. Fathi; Melanie Fiorella; James M. Foran; Steven D. Gore; Aric C. Hall; Patricia Kropf; Jeffrey Lancet; Lori J. Maness; Guido Marcucci; Michael G. Martin; Joseph O. Moore; Rebecca Olin; Deniz Peker; Daniel A. Pollyea; Keith Pratz; Farhad Ravandi; Paul J. Shami; Richard M. Stone; Stephen A. Strick...; Eunice S. Wang; Matthew Wieduwilt; Kristina Gregory; Ndiya Ogba
• Keywords: Leukemia, Myeloid, Acute; 03 medical and health sciences; 0302 clinical medicine; Age Factors; Disease Management; Humans; 3. Good health

Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. This portion of the NCCN Guidelines for AML focuses on management and provides recommendations on the workup, diagnostic evaluation, and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.